Literature DB >> 15484801

Pattern of culture-proven neonatal sepsis in a district general hospital in the United Kingdom.

Khalid N Haque1, M Ajaz Khan, Sally Kerry, Jim Stephenson, Gretta Woods.   

Abstract

OBJECTIVE: To determine the incidence, clinical characteristics, and risk factors associated with the first culture-proven episode of sepsis among neonates in a neonatal intensive care unit (NICU).
SETTING: Level-II NICU in the United Kingdom. PATIENTS: Neonates with their first culture-proven sepsis between January 1, 1996, and December 31, 2000.
METHODS: Demographic data were obtained from the NICU database and chart review. Sepsis was considered early (EOS; < 72 hours old) or late (LOS; > 72 hours old). Data were also collected on potential risk factors.
RESULTS: Among 14,767 live births, 1,612 (11%) neonates were admitted to the NICU during the study period. Nine hundred eight were screened for sepsis. One hundred twenty-four had at least one positive culture (overall sepsis rate of 8.4 per 1,000 live births [1%] or 77 per 1,000 NICU admissions). Twenty-four neonates had EOS and 100 had LOS. Coagulase-negative staphylococci (CoNS) and group B Streptococcus were the most frequent organisms causing EOS, whereas CoNS and Escherichia coli most frequently caused LOS. Birth before 30 weeks' gestation and birth weight less than 1,500 g were risk factors for sepsis. Resuscitation at birth was the leading risk factor for EOS and respiratory support prior to sepsis, presence of a central or peripheral catheter, and total parenteral nutrition were leading risk factors for LOS.
CONCLUSIONS: A strong inverse relationship existed between gestational age of 30 weeks or younger and birth weight of 1,500 g or less and LOS. Resuscitation and indwelling intravenous catheters were also risk factors.

Entities:  

Mesh:

Year:  2004        PMID: 15484801     DOI: 10.1086/502473

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  9 in total

1.  Types of Bacteria associated with Neonatal Sepsis in Al-Thawra University Hospital, Sana'a, Yemen, and their Antimicrobial Profile.

Authors:  Hassan A Al-Shamahy; Amal A Sabrah; Abdul Baki Al-Robasi; Samarih M Naser
Journal:  Sultan Qaboos Univ Med J       Date:  2012-02-07

Review 2.  The host response to sepsis and developmental impact.

Authors:  James Wynn; Timothy T Cornell; Hector R Wong; Thomas P Shanley; Derek S Wheeler
Journal:  Pediatrics       Date:  2010-04-26       Impact factor: 7.124

Review 3.  Pathophysiology and treatment of septic shock in neonates.

Authors:  James L Wynn; Hector R Wong
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

4.  Duration of vancomycin treatment for coagulase-negative Staphylococcus sepsis in very low birth weight infants.

Authors:  Nehama Linder; Daniel Lubin; Adriana Hernandez; Limor Amit; Shai Ashkenazi
Journal:  Br J Clin Pharmacol       Date:  2013-07       Impact factor: 4.335

5.  Maternal and neonatal lipopolysaccharide and Fas responses are altered by antenatal risk factors for sepsis.

Authors:  E J Molloy; A J O'Neill; J J Grantham-Sloan; D W Webb; R W G Watson
Journal:  Clin Exp Immunol       Date:  2007-12-06       Impact factor: 4.330

Review 6.  Defining neonatal sepsis.

Authors:  James L Wynn
Journal:  Curr Opin Pediatr       Date:  2016-04       Impact factor: 2.856

Review 7.  Risk of parenteral nutrition in neonates--an overview.

Authors:  Walter Zingg; Maren Tomaske; Maria Martin
Journal:  Nutrients       Date:  2012-10-16       Impact factor: 5.717

8.  Importance of obtaining lumbar puncture in neonates with late onset septicemia a hospital based observational study from north-west India.

Authors:  Varun Kaul; Rekha Harish; Sandesh Ganjoo; Bella Mahajan; Sunil Kumar Raina; Diptiman Koul
Journal:  J Clin Neonatol       Date:  2013-04

9.  Diagnostic value of urine soluble triggering receptor expressed on myeloid cells (sTREM-1) for late-onset neonatal sepsis in infected preterm neonates.

Authors:  Senem Alkan Ozdemir; Esra Arun Ozer; Ozkan Ilhan; Sumer Sutcuoglu; Mansur Tatlı
Journal:  J Int Med Res       Date:  2018-02-26       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.